Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China

Clinical trial NCT04740996 · UNKNOWN

Trial details

NCT number: NCT04740996
Sponsor: Shi Yuankai
Status: UNKNOWN
Study type: OBSERVATIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2021-02-04
Primary completion: 2024-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.